Amesite Inc. (AMST) stock: key figures, P/E, revenue and dividend
Information Technology · United States · ISIN US0310942042
Amesite Inc. financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 110,459.00 USD | 364,777.00 USD |
| Operating income | -3.60 m USD | -3.14 m USD |
| EBIT | -3.69 m USD | -3.14 m USD |
| Net income | -3.62 m USD | -3.10 m USD |
| Diluted EPS – continuing operations | -1.03 USD | -0.63 USD |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Amesite Inc.
Amesite Inc., a technology company, engages in the marketing and development of B2C and B2B AI-driven solutions in the United States. Its products include Amesite Engage, that leverages proprietary AI infrastructure, offering cutting-edge applications that cater to both individual and professional needs; and NurseMagic, mobile healthcare app, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situation. Amesite Inc. was founded in 2017 and is headquartered in Detroit, Michigan.
More stocks
- GOLD ROCK HOLDINGS, INC. (GRHI)
- DataMeds AI, Inc. (MEDS)
- Advanced Biomed Inc. (ADVB)
- REGIONAL HEALTH PROPERTIES, INC (RHEP)
- bioAffinity Technologies, Inc. (BIAF)
- FLYWHEEL ADVANCED TECHNOLOGY, INC. (FWFW)
- Strive, Inc. (ASST)
- Polomar Health Services, Inc. (PMHS)
- VisitIQ Corp. (VIIQ)
- Borqs Technologies, Inc. (BRQSF)
- CXApp Inc. (CXAI)
- Xenetic Biosciences, Inc. (XBIO)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.